Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Weight loss drug Wegovy is now approved for heart health — but that won't mean broad insurance coverage just yet
Tags Social issues Cigna Corp Biotech and Pharmaceuticals
From CNBC.com News
FDA approves Madrigal Pharmaceuticals drug as first treatment for common NASH liver disease
Tags Biotech and Pharmaceuticals Biotechnology Business
From CNBC.com News
Weight Watchers CEO just sent an internal memo to employees as stock crashes, amid debt concerns, Oprah exit
Tags Obesity Weight loss diets Drugs
From CNBC.com News
Experts hesitate on weight loss ETFs amid the obesity drug boom
Tags Novo Nordisk A/S Exchange/traded funds Stock markets
From CNBC.com News
Eli Lilly taps Amazon Pharmacy to help deliver weight loss drug Zepbound, other medicines to patients
Tags Health care industry Companies Health & Science
From CNBC.com News
Jim Cramer reviews Citi's European 'Super Seven'
Tags Markets Investing stocks
From CNBC.com News
Novo Nordisk's Wegovy wins FDA approval for heart health benefits, in move that could expand insurance coverage
Tags Breaking News: Business Novo Nordisk A/S Social issues
From CNBC.com News
Novo Nordisk CEO says experimental weight loss pill could become a best in class drug
Tags Novo Nordisk A/S Business Biotechnology
From CNBC.com News
Novo Nordisk market cap surpasses Tesla on new obesity pill trial data
Tags Biotech and Pharmaceuticals Europe Markets Markets
From CNBC.com News
Novo Nordisk shares jump 5% on promising weight loss trial results; Eli Lilly dips
Tags U/S/ Markets Health care industry Health & Science
From CNBC.com News
Novo Nordisk's diabetes drug Ozempic slashed the risk of kidney disease progression in trial
Tags Eli Lilly and Co Pharmaceuticals US: News
From CNBC.com News
Cramer says get ready to buy if there's a market sell-off: 'I have my shopping list'
Tags Markets stocks Eli Lilly and Co
From CNBC.com News
Viking Therapeutics emerges as a strong weight loss drug player — or takeover target
Tags Companies Health & Science Health care industry
From CNBC.com News
Europe is having its worst earnings season since the onset of Covid — with little hope of a quick turnaround
Tags Politics Economic events Earnings
From CNBC.com News
5 things to know before the stock market opens Thursday
Tags Paramount Global WW Grainger Inc Economy
From CNBC.com News
CNBC Daily Open: Markets brace for Fed's key inflation gauge
Tags Europe Markets S&P Global Inc Asia Markets
From CNBC.com News
CNBC Daily Open: Wall Street on edge over Fed's key inflation gauge
Tags Alphabet Inc Daily Open Novo Nordisk A/S
From CNBC.com News
The big health decisions Americans will need to make after starting new weight loss drugs
Tags Diets and dieting WW International Inc Weight loss diets
From CNBC.com News
The pet drugs vets are now prescribing look a lot more like human medications
Tickers CATS DOGS PETS
Tags Zoetis Inc Dogs Pharmaceuticals
From CNBC.com News
Healthy Returns: The newest treatment use for weight loss drugs? Liver disease
Tags Eli Lilly and Co Healthy Returns Biotech and Pharmaceuticals
From CNBC.com News
The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisons
Tags Roche Holding AG Novartis AG Novo Nordisk A/S
From CNBC.com News
Novo Nordisk and Eli Lilly rival soars 26% after promising test results
Tags Europe News Pharmaceuticals Markets
From CNBC.com News
What you need to know about health insurance coverage for new weight loss drugs, and how to save on costs
Tags Health & Science Employee benefits Labor economy
From CNBC.com News
Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that
Tags Pfizer Inc Business News Biotechnology
From CNBC.com News
Eli Lilly says weight loss drug shows promise as treatment for fatty liver disease
Tags Eli Lilly and Co Pharmaceuticals US: News
From CNBC.com News
Novo Nordisk parent to buy Catalent for $16.5 billion to expand Wegovy supply
Tags Business Biotechnology Mergers
From CNBC.com News
Novo Nordisk beats earnings expectations as Wegovy, Ozempic demand soars
Tags Europe Markets Biotech and Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Peloton Interactive Inc Novo Nordisk A/S Politics
From CNBC.com News
Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices
Tags Bristol/Myers Squibb Co Johnson & Johnson Sanofi SA
From CNBC.com News
The weight loss drug market may soon get more crowded – here are the companies trying to enter the booming space
Tags Eli Lilly and Co Pharmaceuticals Amgen Inc
From CNBC.com News
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.